Bank of America’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-600
Closed -$44K 7628
2015
Q2
$44K Sell
600
-36,600
-98% -$2.64M ﹤0.01% 6011
2015
Q1
$2.43M Sell
37,200
-105,000
-74% -$6.98M ﹤0.01% 3060
2014
Q4
$9.25M Buy
142,200
+40,700
+40% +$2.62M ﹤0.01% 2001
2014
Q3
$6.1M Buy
101,500
+90,900
+858% +$5.94M ﹤0.01% 2379
2014
Q2
$734K Buy
10,600
+7,700
+266% +$499K ﹤0.01% 4263
2014
Q1
$190K Buy
2,900
+1,000
+53% +$65.1K ﹤0.01% 5483
2013
Q4
$118K Buy
1,900
+900
+90% +$52.1K ﹤0.01% 6004
2013
Q3
$54K Hold
1,000
﹤0.01% 6387
2013
Q2
$46K Buy
+1,000
New +$43.3K ﹤0.01% 6619

Other funds holding STJ

Bank of America's STJ Position: Q1 2017 in Review

Bank of America sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 3,004,373 shares — an estimated $241M sold.

Bank of America first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $259M in Q4 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Bank of America reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Bank of America sold 3,004,373 St Jude Medical shares in Q1 2017, an estimated $241M.
  • Bank of America first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Bank of America's St Jude Medical position peaked at $259M in Q4 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Bank of America's 13F filing for Q1 2017, filed 15 May 2017.